Back to Directory Marisol Martinez-Tristani Email marisol.martinez@abbott.com Phone 305-338-2420 Institution Abbvie Address Abbvie 2000 Towerside Terrace Apt 1501 Miami, FL 33138 United States of America Request an Update Affiliated Studies 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed P1013: Salvage Therapy With Combination PJ's, Ritonavir, and Indinavir DAIDS Number 10191 Research Area Other Study Status Concluded P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded Show All
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
P1013: Salvage Therapy With Combination PJ's, Ritonavir, and Indinavir DAIDS Number 10191 Research Area Other Study Status Concluded
P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded
P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded
P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded